17 авг. 2022 г. · Sanofi will pay Atomwise $20 million upfront to identify, synthesize, and advance lead compounds for up to five targets which will be exclusive to Sanofi.

The new round of funding will support Atomwise's break-out company x-37, which focuses on developing small molecule therapies for endodermal cancers, such as ...

Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or ...

3 дня назад · Atomwise has raised a total funding of $174M over 7 rounds. Its first funding round was on Jan 01, 2013. What are the most recent funding rounds ...

17 авг. 2022 г. · Sanofi is continuing to push the limits of AI-powered drug discovery, inking a $1.2 billion biobucks research collaboration with San Francisco-based Atomwise.

Atomwise, which operates an artificial intelligence (AI)-based drug discovery platform, has raised $163 million CAD ($123 million USD) in what it called an ...

19 нояб. 2024 г. · Atomwise has raised a total funding of $174M over 7 rounds from 29 investors. Investors include DFJ, DCVC and 27 others.

11 авг. 2020 г. · Atomwise, which is using artificial intelligence for small molecule drug discovery, received a cash infusion of $123 million in an oversubscribed Series B ...

Who are Atomwise's investors? Bill & Melinda Gates Foundation, Cerity Partners Ventures, Draper Dragon, Sanabil Investments, and AimTop Ventures are 5 of 28 ...

Atomwise's business model is based on developing and co-developing pipeline assets, which are then backed by investors. This means that the company makes money ...